Close Menu

tuberculosis

NEW YORK (GenomeWeb News) – After years in development, a handheld point-of-care molecular diagnostic device from QuantuMDx is poised to hit the market next year with malaria and tuberculosis as its initial target markets, a company executive said last week on the sidelines of the 32nd Annual JP

NEW YORK (GenomeWeb News) – A new Nature Genetics study hints that a combination of ineffective control strategies and new adaptations by Mycobacterium tuberculosis populations have con

NEW YORK (GenomeWeb News) — Epistem said yesterday that it has entered into cooperative agreements with the US Air Force and Johns Hopkins University's Advanced Physics Laboratory to undertake combat evaluation of Epistem's Genedrive molecular handheld pathogen-detection device.

NEW YORK (GenomeWeb News) – Qiagen said on Monday that its QuantiFeron-TB Gold test has been approved for marketing in China.

NEW YORK (GenomeWeb News) – QuantuMDx said today that it has received a £1 million ($1.6 million) grant from the UK government's Technology Strategy Board to fund a project to develop a rapid test for multi-drug resistant tuberculosis.

A Mayo Clinic research group that previously evaluated Abbott's PCR-electrospray ionization mass spectrometry platform to broadly identify fungal infections has now published research demonstrating the system's ability to identify Mycobacterium species and M.

NEW YORK (GenomeWeb News) – Certara said this week that it is working with the Critical Path Institute, C-Path, to create a physiologically-based pharmacokinetic model of the human lung using Certara's Simcyp Population-based simulator software that will be used to test new tuberculosis drugs.

Over the last six months, nucleic acid testing firm DNA Logix and its molecular diagnostics spinoff Co-Diagnostics have made a flurry of business deals in an attempt to move a new, highly specific PCR technology from the bench to the market.

NEW YORK (GenomeWeb News) – A bevy of studies appearing this week in Nature Genetics traced the evolution of the tuberculosis-causing bacterium from its pre-Neolithic roots to today's modern, and increasingly drug-resistant, strains.

Becton Dickinson's BD Diagnostics segment said this week that the US Food and Drug Administration has cleared the BD ProbeTec Trichomonas vaginalis Qx Amplified DNA Assay on the BD Viper System with XTR technology.

Pages

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.